Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Nicolas, Tsavaris"'
Autor:
Vassiliki Kyriakou, Petros Kopterides, George Arapogiannis, Christos Kosmas, E. Patsouris, Thomas G. Papathomas, Haralambos Zorzos, Nikolaos Kavantzas, Panagiotis Gouveris, Nicolas Tsavaris, Andreas C. Lazaris
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose Human DNA topoisomerases I and II (topo-I and -II) are essential for vital cellular processes such as DNA replication, transcription, translation, recombination, and repair. In the present study, we correlate topo-I and -II expression and out
Autor:
Panagiotis-Vasilis Zis, Eyterpi Pagouni, Petros Kopterides, Nicolas Tsavaris, Skopelitis H, Dimitrios Pikazis, Christos Koufos, Athina Efthymiou, Christos Kosmas, A. Dimitrakopoulos
Publikováno v:
Pain Medicine. 9:1209-1216
Objective. This study was conducted to investigate the efficacy and safety of gabapentin monotherapy in the management of chemotherapy-induced neuropathic pain. Patients. Seventy-five cancer patients who had previously received chemotherapy, and had
Autor:
Elias Skopelitis, Petros Kopterides, Matthew E. Falagas, Eleni G. Mourtzoukou, Nicolas Tsavaris
Publikováno v:
Transactions of the Royal Society of Tropical Medicine and Hygiene. 101:1181-1189
Given the prevalence of leishmaniasis and cancer, the co-existence of these two diseases may be merely coincidental. However, a number of epidemiological, experimental and laboratory studies suggest that an association between these two entities does
Autor:
A. Karabelis, Petros Kopterides, Christos Kosmas, Nicolaos Mylonakis, Helias Skopelitis, John Syrios, Nicolas Tsavaris, Manolis S. Kallistratos
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 134:75-82
Cardiotoxicity associated with 5-Fluorouracil (5FU) administration has been infrequently reported in literature, albeit various series of acute coronary syndromes have recorded a low but definite incidence of the above toxicity. In the present study,
Autor:
Nikolaos A. Malamos, George Tsakonas, Christos Kosmas, Nicolas Tsavaris, Argyris Gassiamis, N. Mylonakis, A. Karabelis, Aristidis Polyzos
Publikováno v:
Investigational New Drugs. 25:463-470
The feasibility of the docetaxel-ifosfamide combination, as well as the definition of maximum tolerated doses (MTD) in a previous phase I study, led us to continue evaluating the regimen in an extended phase II study in patients with HER2-non-overexp
Autor:
Efstathios Adoniou, Helias Skopelitis, Michalis Zacharakis, Nicolas Tsavaris, Christos Bacoyiannis, George C. Zografos, Nicitas Papadoniou, John Gryniatsos, Efstathios Papalambros, Christos Kosmas, Francheska Sigala, George Papastratis, Evangelos Felekouras, Aristidis Polyzos
Publikováno v:
Chemotherapy. 53:282-291
Purpose: The purpose of the present study was to evaluate the differences in the sequence of administration of 5-fluorouracil (5-FU)/leucovorin (LV) followed by irinotecan (CPT-11), or CPT-11 followed by 5-FU/LV in advanced colorectal cancer (ACC). P
Autor:
Christos Kosmas, A. Karabelis, George Tsakonas, Nicolas Tsavaris, George P. Stathopoulos, Thomas Makatsoris, Angelos Koutras, Konstantinos N. Syrigos, Haralambos P. Kalofonos, N. Mylonakis
Publikováno v:
Cancer Chemotherapy and Pharmacology. 59:51-59
Purpose: Treatment options in patients with recurrent non-small cell lung cancer (NSCLC) remain limited as a result of poor activity of most agents after failure of platinum-based therapy. In the present phase I–II study, we evaluated the feasibili
Autor:
Christos Kosmas, Petros Kopterides, Gerasimos Pangalis, Evangelos Patsouris, Marina P. Siakantaris, Nicolas Tsavaris
Publikováno v:
Leukemia & Lymphoma. 47:557-560
Spontaneous remission of acute myeloid leukemia (AML) in adults is a rare but well documented phenomenon. This study reports on a 64-year-old male patient with acute myelogenous leukemia (AML-M4, according to the French-American-British classificatio
Autor:
Paris Papas, George Tzelepis, Sofia Rokana, Kostantinos Gennatas, Nicolas Tsavaris, Elias Skopelitis, Alexandra Zorbala, Christos Kosmas, Panagiotis Gouveris, George Antypas
Publikováno v:
Lung. 183:405-416
The efficacy of the docetaxel-carboplatin combination chemotherapy was studied in various phase II studies. Based on these data we aimed to test the regimen in previously untreated patients with advanced advanced non-smoking lung cancer (NSCLC) with
Publikováno v:
Critical Reviews in Oncology/Hematology. 45:265-275
The activity of single-agent docetaxel in patients with platinum pretreated non-small cell lung cancer (NSCLC) has been established in two recent large randomized phase III trials, either against best supportive care or versus single-agent vinorelbin